Effect of Myriocin on Plasma Sphingolipid Metabolism and Atherosclerosis in apoE-deficient Mice

This publication has 36 references indexed in Scilit:

• Disruption of sphingolipid homeostasis by myriocin, a mycotoxin, reduces thymic and splenic T-lymphocyte populations
  Toxicology, 2004
• Predicting obstructive coronary artery disease with serum sphingosine-1-phosphate
  American Heart Journal, 2003
• Enzymes of Sphingolipid Metabolism: From Modular to Integrative Signaling
  Biochemistry, 2001
• Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels
  Journal of Clinical Investigation, 1999
• Zn2+-stimulated Sphingomyelinase Is Secreted by Many Cell Types and Is a Product of the Acid Sphingomyelinase Gene
  Journal of Biological Chemistry, 1996
• Serine Palmitoyltransferase Is the Primary Target of a Sphingosine-like Immunosuppressant, ISP-1/Myriocin
  Biochemical and Biophysical Research Communications, 1995
• An update of the enzymology and regulation of sphingomyelin metabolism
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1990
• Introduction
  The American Journal of Cardiology, 1990
• Dyslipidemias with desirable plasma total cholesterol levels and angiographically demonstrated coronary artery disease
  The American Journal of Cardiology, 1990
• Activities of the initial enzymes of glycerolipid and sphingolipid synthesis in lung microsomes from rats exposed to air or 85% oxygen
  Biochemical and Biophysical Research Communications, 1984